Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CICERO: Intracoronary vs Intravenous Abciximab in STEMI
NCT00927615Phase 3Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2008
- Primary completion
- May 2010
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of abciximab in ST elevation myocardial infarction (STEMI), sponsored by University Medical Center Groningen. Status: unknown.
02
Drugs
abciximab
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00927615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927615.